BioXcel Therapeutics (BTAI) Operating Margin (QoQ) (2022 - 2026)
Powered by 
Analysis
BioXcel Therapeutics (BTAI) Operating Margin (QoQ) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 212.04 Bn | 198.05 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.35 Bn | 178.17 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.94 Bn | 74.94 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.53 Bn | 56.34 Bn | 1.37 Bn |
| 6 | Moderna | 54.25 Bn | 49.11 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.41 Bn | 31.10 Bn | 992.69 Mn |
| 8 | Biogen | 31.19 Bn | 29.91 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn |
| 10 | BioXcel Therapeutics | 2.19 Mn | 2.19 Mn | 160,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63,793.00 |
| Mar 31, 2026 | -94,622.00 |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | -130,837.00 |
| Jun 30, 2025 | -719,869.00 |
| Mar 31, 2025 | -314,437.00 |
| Dec 31, 2024 | 427,932.00 |
| Sep 30, 2024 | -557,960.00 |
| Jun 30, 2024 | 258,505.00 |
| Mar 31, 2024 | 113,419.00 |
| Dec 31, 2023 | 887,744.00 |
| Sep 30, 2023 | -269,420.00 |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | -262,903.00 |
| Dec 31, 2022 | 623,548.00 |